SciSight Ecosystem
WoS ESCI Q3Scopus Q2SCImago #9,678CAS 4区Gold OA

Current Therapeutic Research-Clinical and Experimental

Abbreviation (ISO):CURR THER RES CLIN E
Country: United States•WoS SCIE Quartile: Q3•Scopus SJR: 0.609•SCImago Rank: #9,678•Identifier (ISSN):0011-393X(Print)/1879-0313(Online)•Articles / Year: 30•Estimated Publication Fee (APC): $2,911 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q3
3
↑ +1.5

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
34

34 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
30articles/year
100% Gold OA•74.07% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 3)
🔵 Computed
20251.50đ
WoS Q2(IF: 1.5)
🔵 Computed
20241.50đ
WoS Q2(IF: 1.6)
🔵 Computed
20231.50đ
WoS Q2(IF: 1.9)
🔵 Computed
20221.50đ
WoS Q2(IF: 0)
🔵 Computed
20211.50đ
WoS Q2(IF: 0)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics. CTR encourages and supports the submission of manuscripts describing: • Interventions designed to understand or improve human health, disease treatment or disease prevention; • Studies that focus on problems that are uncommon in resource-rich countries; • Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing); • Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English; • Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.

Topics Covered (Recognized by AI)
Medicine93.8%Biology83.6%Internal medicine73.4%Chemistry50.6%Endocrinology41.4%Pharmacology40.8%Biochemistry39.5%Psychology36.2%Pathology34.4%Genetics32.1%Psychiatry27.8%Anesthesia26.3%Surgery26.3%Alternative medicine20.1%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,678Scopus Q2SCImago Profile
Scopus Coverage:1959-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.609

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
50

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
3.26

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,911 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations315
3-Year Documents104
Citable Documents102

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q2
PharmacologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1959
Editorial Address
ELSEVIER, 685 ROUTE 202-206, BRIDGEWATER, USA, NJ, 08807
Indexing & Databases
ESCIScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
MEDICINE, RESEARCH & EXPERIMENTAL
JCRESCI
96/191Q3
MEDICINE, RESEARCH & EXPERIMENTAL
JCIESCI
91/191Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—193
20251.54162
20241.644319
20231.937222
2022029267
2021038295
2020—47709
2019—29734
2018—17133
2017—30623
2016—33211
2015—17335
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Current Therapeutic Research-Clinical and Experimental

WoS Q3
0123202120222023202420251.50
Annual Impact Factor Metric
2025:1.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f570d8ec-09fe-408d-875f-2414aacaf92d
Database Updated: 2026-10-01